Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseWilliam J. Sandborn, Asit Parikh, Brian G. Feagan et al.|New England Journal of Medicine|2013Cited by 2.7k
Artificial intelligence in cardiac radiologyMarly van Assen, Carlo N. De Cecco, Giuseppe Muscogiuri et al.|La radiologia medica|2020Cited by 88
Artificial intelligence from A to Z: From neural network to legal frameworkMarly van Assen, Carlo N. De Cecco, Scott Lee|European Journal of Radiology|2020Cited by 61
O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohnʼs Disease Refractory to Anti-TFNαWilliam J. Sandborn, Paul Rutgeerts, Christopher Gasink et al.|Inflammatory Bowel Diseases|2016Cited by 48
PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative ColitisWilliam J. Sandborn, Suneel Gupta, Larry Mattheakis et al.|Gastroenterology|2021Cited by 37